Gundersen Health System invests in Minnesota-based gene editing firm
Gundersen Health System was the lead investor in the most recent funding round for a Minnesota-based company that’s focused on using gene editing to improve treatment for diseases and regenerative medicine.
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.